This is an open-label study in healthy men and women who have been cleared medically for elective total hip replacement surgery.  This study is examining the penetration of Ceftobiprole into bone.

Ceftobiprole is a new chemical entity with bactericidal activity being studied in the treatment of the complicated skin and skin structure infections (cSSI), nosocomial pneumonia (NP), and community acquired pneumonia in hospitalized patients (hCAP).

NO LONGER ENROLLING FOR THIS STUDY.